The wonders of the Wanderer

Experimental Physiology

Volumn 98, Issue 1, 2013, Pages 38-45

  Clancy, Jennifer A ^a   Deuchars, Susan A ^a   Deuchars, Jim ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITUSSIVE AGENT; BRADYKININ; CAPSAICIN; CAPSAZEPINE; CITRIC ACID; NORADRENALIN; RESINIFERATOXIN; THEOBROMINE; VANILLOID RECEPTOR 1;

ALZHEIMER DISEASE; ARTICLE; CACAO; CEREBROVASCULAR ACCIDENT; CHOLINERGIC SYSTEM; CHRONIC COUGH; COUGHING; DEPRESSION; ELECTROACUPUNCTURE; ELECTROENCEPHALOGRAM; EPILEPSY; EPILEPTIC DISCHARGE; FOCAL EPILEPSY; HEART FAILURE; HICCUP; HUMAN; INFLAMMATORY DISEASE; LOCUS CERULEUS; MAJOR DEPRESSION; MIGRAINE; NONHUMAN; NORADRENALIN BLOOD LEVEL; NORADRENERGIC NERVE; OBESITY; PAIN RECEPTOR; PARASYMPATHETIC TONE; PHASE 3 CLINICAL TRIAL (TOPIC); PRESSORECEPTOR REFLEX; RECEPTOR DENSITY; SEROTONINERGIC NERVE CELL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SYMPATHETIC TONE; TINNITUS; TRANSCUTANEOUS NERVE STIMULATION; TREATMENT RESISTANT DEPRESSION; VAGUS NERVE; VAGUS NERVE STIMULATION;

EID: 84872171531     PISSN: 09580670     EISSN: 1469445X     Source Type: Journal    
DOI: 10.1113/expphysiol.2012.064543     Document Type: Article

References (57)

1. Badawy RAB, Harvey AS & Macdonell RAL (2009). Cortical hyperexcitability and epileptogenesis: understanding the mechanisms of epilepsy - part 1. J Clin Neurosci 16, 355-365.
2. Baigi A, Oden A, Almlid-Larsen V, Barrenäs M & Holgers K (2011). Tinnitus in the general population with a focus on noise and stress: a public health study. Ear Hear 32, 787-789.
3. Beleza P (2009). Refractory epilepsy: a clinically oriented review. Eur Neurol 62, 65-71.
4. Brookes SJ, Dinning PG & Gladman MA (2009). Neuroanatomy and physiology of colorectal function and defaecation: from basic science to human clinical studies. Neurogastroenterol Motil 21(Suppl 2), 9-19.
5. Canning BJ (2010). Afferent nerves regulating the cough reflex: mechanisms and mediators of cough in disease. Otolaryngol Clin North Am 43, 15-25.
6. Chien C, Shieh J, Ling E, Tan C & Wen C (1996). The composition and central projections of the internal auriculae nerves of the dog. J Anat 189, 349-362.
7. Collins JJ, Lin CE, Berthoud HR & Papka RE (1999). Vagal afferents from the uterus and cervix provide direct connections to the brainstem. Cell Tissue Res 295, 43-54.
8. Connor DE Jr, Nixon M, Nanda A & Guthikonda B (2012). Vagal nerve stimulation for the treatment of medically refractory epilepsy: a review of the current literature. Neurosurg Focus 32, E12.
9. Corning JL (1884). Electrization of the sympathetic and pneumogastric nerves, with simultaneous bilateral compression of the carotids. New York Medical Journal 39, 212-215.
10. De Ferrari GM, Crijns HJGM, Borggrefe M, Milasinovic G, Smid J, Zabel M, Gavazzi A, Sanzo A, Dennert R, Kuschyk J, Raspopovic S, Klein H, Swedberg K & Schwartz PJ; CardioFit Multicenter Trial Investigators (2011). Chronic vagus nerve stimulation: a new and promising therapeutic approach for chronic heart failure. Eur Heart J 32, 847-855.
11. De Herdt V, Bogaert S, Bracke KR, Raedt R, De Vos M, Vonck K & Boon P (2009). Effects of vagus nerve stimulation on pro- and anti-inflammatory cytokine induction in patients with refractory epilepsy. J Neuroimmunol 214, 104-108.
12. Dicpinigaitis PV (2011). Cough: an unmet clinical need. Br J Pharmacol 163, 116-124.
13. Dorr AE & Debonnel G (2006). Effect of vagus nerve stimulation on serotonergic and noradrenergic transmission. J Pharmacol Exp Ther 318, 890-898.
14. DuBois FS & Foley JO (1936). Experimental studies on the vagus and spinal accessory nerves in the cat. The Anatomical Record 64, 285-307.
15. Dunlap ME, Bibevski S, Rosenberry TL & Ernsberger P (2003). Mechanisms of altered vagal control in heart failure: influence of muscarinic receptors and acetylcholinesterase activity. Am J Physiol Heart Circ Physiol 285, H1632-H1640.
16. Eckberg DL, Drabinsky M & Braunwald E (1971). Defective cardiac parasympathetic control in patients with heart disease. N Engl J Med 285, 877-883.
17. Engineer ND, Riley JR, Seale JD, Vrana WA, Shetake JA, Sudanagunta SP, Borland MS & Kilgard MP (2011). Reversing pathological neural activity using targeted plasticity. Nature 470, 101-104.
18. Fesmire FM (1988). Termination of intractable hiccups with digital rectal massage. Ann Emerg Med 17, 872.
19. Fornai F, Ruffoli R, Giorgi FS & Paparelli A (2011). The role of locus coeruleus in the antiepileptic activity induced by vagus nerve stimulation. Eur J Neurosci 33, 2169-2178.
20. Gans JH, Korson R, Cater MR & Ackerly CC (1980). Effects of short-term and long-term theobromine administration to male dogs. Toxicol Appl Pharmacol 53, 481-496.
21. Gupta D, Verma S & Vishwakarma S (1986). Anatomic basis of Arnold's ear-cough reflex. Surg Radiol Anat 8, 217-220.
22. Harden CL, Pulver MC, Ravdin LD, Nikolov B, Halper JP & Labar DR (2000). A pilot study of mood in epilepsy patients treated with vagus nerve stimulation. Epilepsy Behav 1, 93-99.
23. Imai K, Sato H, Hori M, Kusuoka H, Ozaki H, Yokoyama H, Inoue M & Kamada T (1994). Vagally mediated heart rate recovery after exercise is accelerated in athletes but blunted in patients with chronic heart failure. J Am Coll Cardiol 24, 1529-1535.
24. Komisaruk BR, Whipple B, Crawford A, Grimes S, Liu W, Kalnin A & Mosier K (2004). Brain activation during vaginocervical self-stimulation and orgasm in women with complete spinal cord injury: fMRI evidence of mediation by the vagus nerves. Brain Res 1024, 77-88.
25. Krahl SE, Clark KB, Smith DC & Browning RA (1998). Locus coeruleus lesions suppress the seizure-attenuating effects of vagus nerve stimulation. Epilepsia 39, 709-714.
26. Kraus T, Hösl K, Kiess O, Schanze A, Kornhuber J & Forster C (2007). BOLD fMRI deactivation of limbic and temporal brain structures and mood enhancing effect by transcutaneous vagus nerve stimulation. J Neural Transm 114, 1485-1493.
27. Langer S, Marshall LJ, Day AJ & Morgan MRA (2011). Flavanols and methylxanthines in commercially available dark chocolate: a study of the correlation with nonfat cocoa solids. J Agric Food Chem 59, 8435-8441.
28. Li M, Zheng C, Sato T, Kawada T, Sugimachi M & Sunagawa K (2004). Vagal nerve stimulation markedly improves long-term survival after chronic heart failure in rats. Circulation 109, 120-124.
29. A receptor density and vagus nerve stimulation in individuals with drug-resistant partial epilepsy. Epilepsy Res 55, 59-70.
30. Martin JLR & Martín-Sánchez E (2012). Systematic review and meta-analysis of vagus nerve stimulation in the treatment of depression: variable results based on study designs. Eur Psychiatry 27, 147-155.
31. Nasra J & Belvisi MG (2009). Modulation of sensory nerve function and the cough reflex: understanding disease pathogenesis. Pharmacol Ther 124, 354-375.
32. Nolan J, Batin PD, Andrews R, Lindsay SJ, Brooksby P, Mullen M, Baig W, Flapan AD, Cowley A, Prescott RJ, Neilson JMM & Fox KAA (1998). Prospective study of heart rate variability and mortality in chronic heart failure: results of the United Kingdom heart failure evaluation and assessment of risk trial (UK-Heart). Circulation 98, 1510-1516.
33. Nomura S & Mizuno N (1984). Central distribution of primary afferent fibers in the Arnold's nerve (the auricular branch of the vagus nerve): a transganglionic HRP study in the cat. Brain Res 292, 199-205.
34. Odeh M, Bassan H & Oliven A (1990). Termination of intractactable hiccups with digital rectal massage. J Intern Med 227, 145-146.
35. Palmeri ST, Kostis JB, Casazza L, Sleeper LA, Lu M, Nezgoda J & Rosen RS (2007). Heart rate and blood pressure response in adult men and women during exercise and sexual activity. Am J Cardiol 100, 1795-1801.
36. Payne BR, Tiel RL, Payne MS & Fisch B (2005). Vagus nerve stimulation for chronic intractable hiccups. Case report. J Neurosurg 102, 935-937.
37. Penry JK & Dean JC (1990). Prevention of intractable partial seizures by intermittent vagal stimulation in humans: preliminary results. Epilepsia 31, S40-S43.
38. Peuker ET & Filler TJ (2002). The nerve supply of the human auricle. Clin Anat 15, 35-37.
39. Porter BA, Khodaparast N, Fayyaz T, Cheung RJ, Ahmed SS, Vrana WA, Rennaker RL 2nd & Kilgard MP (2011). Repeatedly pairing vagus nerve stimulation with a movement reorganizes primary motor cortex. Cereb Cortex, doi: 10.1093/cercor/bhr316.
40. Reynolds SM, Mackenzie AJ, Spina D & Page CP (2004). The pharmacology of cough. Trends Pharmacol Sci 25, 569-576.
41. Roberge R, Anderson E, MacMath T, Rudoff J & Luten R (1987). Termination of paroxysmal supraventricular tachycardia by digital rectal massage. Ann Emerg Med 16, 1291-1293.
42. Ruffoli R, Giorgi FS, Pizzanelli C, Murri L, Paparelli A & Fornai F (2011). The chemical neuroanatomy of vagus nerve stimulation. J Chem Neuroanat 42, 288-296.
43. Rush AJ, Marangell LB, Sackeim HA, George MS, Brannan SK, Davis SM, Howland R, Kling MA, Rittberg BR, Burke WJ, Rapaport MH, Zajecka J, Nierenberg AA, Husain MM, Ginsberg D & Cooke RG (2005a). Vagus nerve stimulation for treatment-resistant depression: a randomized, controlled acute phase trial. Biol Psychiatry 58, 347-354.
44. Rush AJ, Sackeim HA, Marangell LB, George MS, Brannan SK, Davis SM, Lavori P, Howland R, Kling MA, Rittberg B, Carpenter L, Ninan P, Moreno F, Schwartz T, Conway C, Burke M & Barry JJ (2005b). Effects of 12 months of vagus nerve stimulation in treatment-resistant depression: a naturalistic study. Biol Psychiatry 58, 355-363.
45. Sabbah H, Ilsar I, Zaretsky A, Rastogi S, Wang M & Gupta R (2011). Vagus nerve stimulation in experimental heart failure. Heart FailRev 16, 171-178.
46. Schnupp J (2011). Auditory neuroscience: how to stop tinnitus by buzzing the vagus. Curr Biol 21, R263-R265.
47. Schosser A, Serretti A, Souery D, Mendlewicz J, Zohar J, Montgomery S & Kasper S (2012). European group for the study of resistant depression (GSRD) - where have we gone so far: review of clinical and genetic findings. Eur Neuropsychopharmacol 22, 453-468.
48. Schwartz PJ, De Ferrari GM, Sanzo A, Landolina M, Rordorf R, Raineri C, Campana C, Revera M, Ajmone-Marsan N, Tavazzi L & Odero A (2008). Long term vagal stimulation in patients with advanced heart failure: first experience in man. Eur J Heart Fail 10, 884-891.
49. Schweitzer A & Wright S (1937). The anti-strychnine action of acetylcholine, prostigmine and related substances, and of central vagus stimulation. J Physiol 90, 310-329.
50. Shahwan A, Bailey C, Maxiner W & Harvey AS (2009). Vagus nerve stimulation for refractory epilepsy in children: more to VNS than seizure frequency reduction. Epilepsia 50, 1220-1228.
51. Terry R, Tarver WB & Zabara J (1990). An implantable neurocybernetic prosthesis system. Epilepsia 31, S33-S37.
52. Triposkiadis F, Karayannis G, Giamouzis G, Skoularigis J, Louridas G & Butler J (2009). The sympathetic nervous system in heart failure: physiology, pathophysiology, and clinical implications. J Am Coll Cardiol 54, 1747-1762.
53. Usmani OS, Belvisi MG, Patel HJ, Crispino N, Birrell MA, Korbonits M, Korbonits D & Barnes PJ (2004). Theobromine inhibits sensory nerve activation and cough. FASEB J 19, 231-233.
54. Vanoli E, De Ferrari GM, Stramba-Badiale M, Hull SS Jr, Foreman RD & Schwartz PJ (1991). Vagal stimulation and prevention of sudden death in conscious dogs with a healed myocardial infarction. Circ Res 68, 1471-1481.
55. Zamotrinsky A, Afanasiev S, Karpov RS & Cherniavsky A (1997). Effects of electrostimulation of the vagus afferent endings in patients with coronary artery disease. Coron Artery Dis 8, 551-557.
56. Zanchetti A, Wang SC & Moruzzi G (1952). The effect of vagal afferent stimulation on the EEG pattern of the cat. Electroencephalogr Clin Neurophysiol 4, 357-361.
57. Zhang Y, Popovic Z, Bibevski S, Fakhry I, Sica D, Van Wagoner D & Mazgalev TN (2009). Chronic vagus nerve stimulation improves autonomic control and attenuates systemic inflammation and heart failure progression in a canine high-rate pacing model. Circ Heart Fail 2, 692-699.